After experiencing a brief boost during the COVID-19 pandemic, the pharma industry’s reputation has begun to drop again in the public’s eye, according to a recent report. Pharma’s corporate reputation ...

Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco ...

Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Matt Gaetz has claimed congressional committees are declining to ...

Traws Pharma, Inc. announced promising results for ratutrelvir, a main protease inhibitor for COVID-19, suggesting it can be administered without ritonavir, potentially reducing the risk of drug ...

After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s potential as a COVID-19 treatment for U.S. patients, Shionogi has secured an FDA green light for the medicine in the ...

Wastewater signals show BA.3.2 across 25 states, while NWSS funding reductions threaten program continuity after FY2025, diminishing national situational awareness for emerging variants. Genomic ...

After wreaking havoc on a pandemic level for more than three years, COVID-19 has entered its first endemic season. The glorious days of COVID products are gone as companies cut costs, record revenue ...

WAKEFIELD, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report today that a Machine ...

What are antiviral treatments, how can you access them if you're eligible and how important are they in our pandemic response ...